Fosun Pharma Sells Gland Pharma Shares, Stake Drops to 45.41%

Fosun Pharma Industrial Pte. Ltd. has sold 98,97,000 equity shares of Gland Pharma Limited, reducing its total holding to 7,54,96,894 shares, representing 45.41% of the total diluted capital. The sale, conducted via the open market, resulted in a decrease of 6.00% in voting rights and 5.95% in diluted capital for Fosun Pharma. The transaction occurred on September 4, 2026. Gland Pharma's total equity share capital is 164,966,661 shares of ₹1 each.